First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

✍ Scribed by Kenjiro Aogi; Norikazu Masuda; Shinji Ohno; Takashi Oda; Hiroji Iwata; Masahiro Kashiwaba; Yasuhiro Fujiwara; Shunji Kamigaki; Yoshinori Ito; Takayuki Ueno; Shigemitsu Takashima

• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 308 KB
• Volume: 129
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1685-x